Skip to main content
Premium Trial:

Request an Annual Quote

KeyGene, Floragenex Settle Patent Dispute, Enter Licensing Deal

NEW YORK (GenomeWeb News) – KeyGene and Floragenex today said that they have agreed to end a legal dispute and have entered into a licensing agreement covering sequence-based genotyping technology.

KeyGene had filed the patent infringement suit against Floragenex last year in the US District Court for the District of Orgeon.

Under terms of the agreement announced today, Oregon-based Floragenex has taken a non-exclusive, royalty-bearing license to KeyGene's intellectual property. The deal enables it to continue applying its Restriction-site Associated DNA method in specified fields including non-commercial and academic research in all species.

Further terms of the agreement ere not disclosed.

"Floragenex and KeyGene share share the belief that genotyping with next-generation sequencing technology holds tremendous promise for applications in all species," Floragenex President Rick Nipper said in a statement. "The power of sequencing platforms today and in the future open up new markets and opportunities for RADseq and similar applications as substitutes for fixed content genotyping arrays."

The Scan

Suicidal Ideation-Linked Loci Identified Using Million Veteran Program Data

Researchers in PLOS Genetics identify risk variants within and across ancestry groups with a genome-wide association study involving veterans with or without a history of suicidal ideation.

Algorithm Teases Out Genetic Ancestry in Individuals at Biobank Scale

Researchers develop an algorithm known as Rye to tease apart ancestry fractions in admixed individuals at a biobank-scale, applying it to 488,221 UK Biobank participants in Nucleic Acids Research.

Multi-Ancestry Analysis Highlights Comparable Common Variants at Complex Trait-Linked Loci

Researchers in Nature Genetics examine common variants implicated in more than three dozen conditions, estimating genetic effect similarities across ancestry tracts in admixed individuals.

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.